1. Introduction
Essential trace elements are chemical elements required in very small or trace concentrations for the development and physiology of all organisms. Despite their small concentrations, they are vital to all forms of life and act as structural or catalytic components of larger molecules [
1,
2,
3]. About a third of all proteins have a metallic atom in their molecular composition with many of them being enzymes [
4,
5,
6]. Deficiency and excess of essential trace elements or their abnormal spatial distribution in human cells, tissues, and organs were linked to many human diseases and conditions [
7,
8,
9,
10].
Clinical blood tests are essential tools in the diagnosis and screening of human conditions and diseases in modern medicine. The tests range from concentration measurements of hormones, metabolites, major, minor, and essential trace elements to an ever-increasing number of genetic tests. The wide range of clinically available blood tests underscores both the technological advances and the fundamental knowledge that medical sciences gained over the past century. Blood tests targeting levels of essential trace elements such as sodium (Na), potassium (K), calcium (Ca), zinc (Zn), iron (Fe), copper (Cu), manganese (Mn), and magnesium (Mg) are routinely used for diagnosis and research of cardiovascular conditions [
11], iron deficiency and iron-deficiency anemia [
12], or kidney injury [
13]. More recent investigations also found links between essential trace element levels in the blood and other conditions such as autism spectrum disorders, neurodegenerative conditions [
14,
15], systemic inflammatory response syndrome (SIRS), and immune disorders [
16,
17]. Measurements of trace elemental concentrations in human blood are also used in environmental studies of pollution and assessing the uptake of toxic elements including lead (Pb), arsenic (As), cadmium (Cd), and mercury (Hg) [
8,
18,
19].
A relevant example of the importance of measuring essential trace elemental concentrations in human blood is the clinical diagnosis of iron deficiency and iron-deficiency anemia. These conditions affect over 1.2 billion people worldwide [
20]. Iron metabolism, multiple body stores, intestinal iron absorption, erythropoiesis (red blood cell production), and iron recycling are complex processes [
12,
20,
21]. There are also multiple causes of iron deficiency and associated symptoms. Diagnosis of iron deficiency and related conditions is not straightforward, and multiple biomarkers have been proposed, including whole-blood iron concentration [
12]. Immunoradiometric assay measurement of ferritin (iron-filled intracellular protein) concentration in serum, proposed several decades ago [
22], is considered the most sensitive and specific test for iron deficiency [
12,
21]. Ferritin serum concentrations below 30 µg/L and 10 µg/L indicate iron deficiency and iron-deficiency anemia, respectively [
12]. Diagnostic thresholds, however, do not apply to all patients, such as those suffering from chronic inflammation and infection because the immune system response increases ferritin serum concentrations [
20,
23].
The range of normal iron concentrations in human blood indicated by Camaschella [
12] was 10 to 30 µmol/L, which is equivalent to 0.56 to 1.7 mg/L and consistent with measured values provided in
Table 1 below. To the best of our knowledge, there are no iron blood concentration thresholds for iron deficiency or iron overload, but values outside the normal range can indicate an iron imbalance. The literature appears to point out that no single test will likely be sufficient for an accurate diagnosis of iron deficiency or overload. Development of affordable, fast, and clinically applicable tests probing the iron status is ongoing. Recent publications reported novel rapid diagnostic point-of-care tests of iron status [
24,
25]. Our research reported here falls within this scope and will guide the advancement of instrumentation and measurement methods for monitoring the trace elemental concentrations of large populations.
Many clinical and environmental research measurements of trace elemental concentrations in the human tissues are performed employing inductively coupled plasma mass spectrometry (ICP-MS) instrumentation developed in the early 1980s [
26]. ICP-MS techniques can measure accurately trace concentrations as low as one picogram (10
−12 g) per gram [
27]. Clinical applications of ICP-MS, however, have certain disadvantages. In addition to the equipment acquisition cost (~USD 200,000), ICP-MS instruments require a supply of high-purity (>99.999%) argon and/or helium gases for plasma production and adequate certified reference materials for accurate quantitative results [
27]. After collection and before analysis, storage conditions (room temperature, refrigerated, or frozen) of blood samples require adequate preservatives, anticoagulants, and other additives [
28]. Avoiding or minimizing external contamination during sample storage, water dilution, and sample handling devices implies strict adherence to an established measurement protocol [
29].
X-ray fluorescence elemental concentration measurements are simpler, faster, and less costly than ICP-MS, and they typically have a low radiation dose [
30,
31,
32,
33]. XRF techniques can be applied to in vivo measurements of essential or toxic trace elements in the human body [
34,
35]. Photoelectric absorption of X-rays by atoms in the sample triggers the emission of photoelectrons, characteristic (or fluorescent) X-rays, and Auger electrons. Strong electron–electron interactions restrict energy and momentum measurements of Auger electrons and photoelectrons to surface science in vacuum. XRF photons have sufficient energy to escape the irradiated sample and be detected. Their measured energy and count rate can identify a wide range of chemical elements from sodium (Na) to uranium (U) [
36]. XRF elemental detection limits depend on several physical parameters related to the specific method or technique employed, measurement conditions, sample, and instrumentation. Also, the determination of accurate elemental concentrations from experimental data requires a robust calibration method. Detection limits at the level of one microgram (10
−6) per gram were achieved by portable and table-top XRF instruments in ambient conditions and employing low-dose irradiations of only several minutes [
30,
37,
38].
XRF measurements of trace elemental concentrations in ex vivo human whole blood and serum samples were performed in several studies over the past few decades [
39,
40,
41,
42,
43,
44,
45]. An XRF instrument capable of performing a fast and cost-effective in vivo measurement of essential trace elemental concentrations in the superficial cutaneous blood would be a valuable clinical tool. To the best of our knowledge, no such instrument was developed. In this study, we used a detection method employing a custom table-top microbeam XRF system that mitigates X-ray scatter and effective dose [
38,
46].
Concentrations of essential trace elements in human blood vary. There are interindividual variations in the same element concentrations and intraindividual variations amongst the blood elemental concentrations.
Table 1, provided below, summarizes Fe, Cu, Zn, and Se concentrations in human blood from worldwide population studies reported in the last two decades. Using the average human blood density of 1.06 g/mL [
47], the 1 mg/L unit of whole-blood concentration is equivalent to a 0.943 μg/g mass concentration. In the XRF study of Farquharson and Bradley [
48], the detection limit of Fe in the skin was estimated to be (15 ± 2) μg/g. This value is well below the population Fe blood concentrations in
Table 1 and the lowest value of 207 μg/g (219 mg/L/1.06 g/mL) reported in the XRF-based study of Khuder et al. [
42]. The reported measurements of Fe and Zn concentrations in the epidermis and dermis layers of the skin vary roughly between 10 μg/g and 250 μg/g for Fe and 10 μg/g and 150 μg/g for Zn [
49,
50,
51,
52] with demonstrated nonuniform depth distribution [
50,
53,
54,
55]. Thus, expected blood Fe concentrations are, on average, larger than those in normal skin by a factor of four, while Zn concentrations in skin (averaged over skin depth distribution) are slightly larger than those in blood. Reported Cu concentrations in normal and diseased human skin range between 0.5 μg/g and 4.3 μg/g [
56]. Normal skin Se concentrations were measured to be between 0.2 μg and 0.8 μg per gram of dry skin with slightly different concentrations in the dermis and epidermis layers [
49,
57]. XRF detection limits of Se in skin below 1 μg/g were demonstrated [
58,
59]. Thus, the largest value of skin Cu concentrations is larger than the reported blood Cu concentrations, and reported Se skin concentrations are larger than those reported in blood.
Our phantom-based study tested the feasibility of rapid in vivo measurement of four essential trace elements (Fe, Cu, Zn, and Se) in human blood. XRF detection limits of Fe, Cu, Zn, and Se in the superficial cutaneous blood pool were determined from experiments using six solutions of varying concentrations of the four elements, two polyoxymethylene (POM) (chemical formula (CH2O)n) cylindrical cups of 0.6 mm and 1.0 mm wall thickness and a 5.3 mm diameter polyoxymethylene cylinder inserted in the 0.6 mm wall cup. The cylindrical POM cups simulated X-ray attenuation in skin layers and cutaneous vasculature while the solutions mimicked the cutaneous blood volume. The cylindrical insert reduced the solution volume probed by the X-ray beam to better simulate the lower blood volume of cutaneous microvasculature or superficial blood vessels. The distribution and expected concentrations of the four trace elements in the human skin were not simulated in this study.
XRF detectability of other essential trace elements present in human blood was not measured because their concentrations are well below the ~1 μg/g capability of common XRF techniques. In the study of Yedomon et al. [
60], ICP-MS measurements of 20 trace elements in the whole blood of 70 healthy volunteers indicated that only Fe, Cu, Zn, and Se had average blood concentrations above 100 µg/L. The observation was supported by other population studies of human whole-blood elemental composition conducted over the past two decades [
42,
61,
62,
63,
64,
65].
A detailed review of the health implications associated with the deficiency or excess of the four essential trace elements under study is beyond the scope of this paper. However, reviews of current assessment methods indicate a need for clinical biomarkers [
63,
64,
65,
66]. Blood concentrations of essential trace elements are important biomarkers. Low cost, ease of use, and access are important characteristics of novel instruments for clinical applications. Our objective was to measure the detection limits of four elements (Fe, Cu, Zn, and Se) in human blood using phantoms that simulated the X-ray attenuation of skin and blood tissues expected during an in vivo measurement.
Table 1.
Table of Fe, Cu, Zn, and Se concentrations measured in human whole blood in mg/L units.
Table 1.
Table of Fe, Cu, Zn, and Se concentrations measured in human whole blood in mg/L units.
Element | Z | Range | Arithmetic Mean | Geometric Mean | Median | Ref. |
---|
Min | Max |
---|
Fe | 26 | 387 | 554 | 472 | 469 | 476 | [60] |
| | 468 | 631 | | 541 | | [61] |
Cu | 29 | 0.720 | 1.020 | 0.875 | 0.870 | 0.873 | [60] |
| | 0.820 | 1.270 | | 1.010 | | [61] |
| | 0.610 | 1.900 | | | 0.920 | [63] |
| | 0.720 | 1.800 | 1.042 | 1.020 | | [62] |
| | 0.776 | 1.495 | | 1.036 | 1.011 | [64] |
| | 0.580 | 1.590 | | | 0.795 | [65] |
| | 0.650 | 1.420 | 0.840 | | | [66] |
| | 0.676 | 1.837 | 1.078 | | 1.040 | [67] |
Zn | 30 | 3.684 | 8.585 | 4.938 | 4.845 | 4.863 | [60] |
| | 5.900 | 9.100 | | 7.500 | | [61] |
| | 6.100 | 3.100 | | | 9.800 | [62] |
| | 4.686 | 8.585 | | 6.418 | 6.387 | [64] |
| | 3.700 | 7.250 | | | 5.477 | [65] |
| | 4.620 | 9.250 | 6.750 | | | [66] |
| | 4.424 | 17.152 | 8.085 | | 7.629 | [67] |
| | 4.770 | 7.272 | 5.876 | 5.805 | 5.844 | [68] |
Se | 34 | 0.075 | 0.137 | | 0.100 | | [61] |
| | 0.110 | 0.055 | | | 0.180 | [62] |
| | 0.085 | 0.182 | 0.133 | 0.132 | | [63] |
| | 0.106 | 0.185 | | 0.140 | 0.138 | [64] |
| | 0.080 | 0.155 | | | 0.110 | [65] |
| | 0.118 | 0.224 | 0.141 | | | [66] |
| | 0.061 | 0.201 | 0.115 | | 0.113 | [67] |
2. Materials and Methods
2.1. XRF Experimental Setup
The XRF experimental setup consisted of three important independent components: (i) an integrated X-ray tube and polycapillary X-ray lens (PXL) system (Polycapillary X-beam Powerflux model, X-ray Optical Systems, East Greenbush, NY, USA), (ii) a computer-controlled silicon drift X-ray detector (SDD) with an integrated pulse-height analyzer (X-123 SDD model, Amptek Inc., Bedford, MA, USA), and (iii) a positioning stage assembly of two orthogonal linear positioning stages (Newport, Irving, CA, USA). A simplified view from the top schematic of the experimental setup is shown in
Figure 1 below.
The continuous emission X-ray tube was air-cooled, and its target was made of tungsten (W). The X-ray tube’s maximum values of voltage and current for XRF measurements were 50 kV and 1 mA, respectively. An eight-slot wheel, in which custom-made filters could be placed, was used to filter the PXL X-ray beam. A 1.8 mm aluminum (Al) filter was used during all XRF experiments. An Al collimator of 20 mm length and 1.8 mm thickness was custom built and attached to the end of the X-ray detector to reduce the number of scattered and stray X-rays reaching the detector. The distance between the detector Be window and the outer edge of the collimator was 11 mm.
The integrated PXL was 10 cm in length with a 1 cm outer diameter and focused the X-rays generated by the X-ray tube into a small X-ray beam, referred to herein as microbeam. The X-rays converge towards a focal point at distances smaller than the focal length and are divergent at larger distances. Manufacturer specifications and our past measurements determined that the PXL had a focal length of 4 mm. In a previous study, the lateral size of the microbeam as a function of photon energy was measured by employing the knife-edge method and XRF measurements of thin metallic wires [
69]. Photon energy affects the geometrical properties of PXL-produced microbeams described by focal length, FWHM as a function of distance from PXL, and microbeam angular divergence. At the focal point, the microbeam had a 24 μm lateral size measured as the full width at half maximum (FWHM) at the 10 keV photon energy. The microbeam’s angular divergence was measured at a distance larger than the 4 mm focal length to be about 76 milli radians (or 4.35°). Using these measurements, the FWHM of the microbeam at 15 mm from the PXL was estimated to be 1.7 mm [
46].
The area of the SDD was 25 mm2, and its thickness was 0.5 mm. The detector window was made of beryllium (Be) with a 12.5 μm thickness. Energy resolution of the detector given as FWHM at 5.895 keV photon energy was 129 eV, and its count rate capability of 106 photons/s was given by the manufacturer.
The X-ray detector and the plastic support of the POM phantom (described in
Section 2.2 below) were mounted on the two motorized orthogonal positioning stage assemblies using a custom-made support used in previous studies. Therefore, the distance between the detector and the POM phantom was kept constant, while the detector phantom assembly could be precisely placed at different positions relative to the fixed microbeam. A custom-made 3D-printed plastic support for the POM cylindrical cups was firmly attached to the Al support and can be seen in
Figure 2. The setup was used to implement the optimal grazing-incidence position (OGIP) method previously developed in our lab [
38] and described in
Section 2.3.
The XRF setup described above was inside a stainless-steel X-ray shield cover and supported by a thick (6.35 mm) Al rectangular plate measuring 56 cm by 62 cm. The XRF setup and shield assembly was placed on an optical table (Newport, Irving, CA, USA). The shield was manually opened and closed during the experiments. The on/off status of the microbeam was signaled by a green light connected to the power box and controller of the X-ray tube and PXL system. A laptop computer operated the X-ray tube, detector, and positioning unit, and it was also placed on the optical table.
2.2. Standard Solutions and POM Phantoms
Four atomic absorption standard solutions containing Fe, Zn, Se, and Cu (Sigma-Aldrich, St. Louis, MO, USA) were purchased. The solvent was a diluted water-based nitric acid (HNO
3) solution. Manufacturer-provided elemental concentrations of these standard solutions
, initial solution volumes (
), and their corresponding elemental masses
are indicated in
Table 2.
Five solutions containing unique Fe, Cu, Zn, and Se concentrations were prepared by diluting the four solutions mixture with initial volume
(addition of the 5th column values in
Table 2) with predetermined distilled water volumes (
). A sixth distilled water volume was considered the ‘blank’ sample in this study. The relationship between water volume
and elemental concentration
is
The uncertainty on concentration
was denoted by
and was computed using error propagation of independent uncertainties [
70] yielding the following equation:
Table 3 provides the values of the added water volume
and the corresponding elemental concentrations in the five aqueous solutions used in this study as blood phantoms. For solutions with a higher desired concentration of elements and less distilled water, a 1 mL pipette was used to pour the solutions into the POM cylinder. For a smaller desired concentration, a 25 mL cylinder was also used. Fe concentrations were selected to be 10 times higher than that of the other trace elements to match the proportionally higher Fe concentrations in human blood as indicated in
Table 1.
Two custom-made polyoxymethylene (POM) plastic cylinders with wall thicknesses of 0.6 mm and 1.0 mm were machined out of a larger cylinder. All geometrical dimensions of the two cylindrical cups are grouped in
Table 4. Both cylindrical cups were suspended through a round hole of the custom 3D-printed plastic support by an enlarged outer diameter on the upper part of both cups. A digital photograph of the 1.0 mm wall cup suspended from its support in front of the collimator is shown in
Figure 2.
A separate solid POM cylinder of 5.3 mm diameter and 4.9 cm length was also machined. When inserted in the 6.3 mm inner diameter of the 0.6 mm wall cup, the solution would fill a cylindrical shell space defining a circular gap of 0.5 mm. Thus, three phantom configurations of the three POM fixtures were used: (1) 1.0 mm wall cup, (2) 0.6 mm wall cup without insert, and (3) 0.6 mm wall cup with insert. The varying wall thickness, cylindrical insert, and solutions approximately simulated the expected in vivo variations in the combined blood, microvasculature, and skin X-ray attenuation. The 0.6 mm wall cup with insert configuration was a simplified simulation of the superficial microvasculature plexus of the skin [
71]. The two POM cylindrical cups simulated large superficial blood vessels lacking the intricate morphology of the cutaneous microvasculature.
Table 5 below shows the X-ray linear attenuation coefficient (µ) of water, POM, and human blood and skin tissues at four photon energies: 5, 10, 15, and 20 keV. All K-shell XRF photon emissions of the four essential trace elements studied fall in the 5 keV to 20 keV photon energy range [
72]. The µ values were computed as the product between mass attenuation coefficient (
) and mass density (
). Mass attenuation coefficients
were computed using the online XCOM database [
73] using known chemical formulae for water and POM, (CH
2O)
n, and bulk elemental composition of human blood and skin tissues from ICRU Report 44 [
74]. Aqueous solution 5 in the third row of
Table 5 refers to the aqueous solution with elemental concentrations specified in the last row of
Table 3. Using the X-ray linear attenuation coefficient values of
Table 5, one can compute that blood is, on average, about 6.7% more attenuating than aqueous solution 5, and POM is about 7.4% more attenuating than human skin. Therefore, the more attenuating POM is approximately compensated by the less attenuating aqueous solutions in the 5 to 20 keV photon energy range.
2.3. XRF Experimental Procedures
The POM cylindrical cup was filled with the standard solutions and was placed in the 3D-printed support attached to the linear positioning stage as indicated in the previous
Section 2.1.
The OGIP method was employed to find the relative microbeam-sample position that maximized XRF elemental detection. X-ray spectra of 30 s duration were acquired at sequential positions of the phantom in equal 0.5 mm steps, bringing the phantom and X-ray detector assembly closer to the microbeam. The initial position was randomly selected, such that the microbeam was tangent to the cylindrical POM phantom, as shown in
Figure 2. Fe K⍺ peak area data using the highest concentration (500 mg/L Fe concentration and corresponding 50 mg/L concentration of Zn, Se, and Cu in 1.4 mL distilled water) were used to find the optimal position. The Fe K⍺ peaks were selected to determine OGIP because of the higher concentration of Fe in human blood compared with other trace elements. The optimal position corresponded to the maximum of the convolution function between Gaussian and exponential functions which was fitted to the Fe Kα peak area versus position data obtained after the sequence of 10 s X-ray spectra acquisitions separated by 0.5 mm steps given in the expressions provided below [
75].
In Equation (3), the normalized functions
and
are given as
The
and
parameters represent the center and standard deviation of the Gaussian function, while
µ is the linear attenuation coefficient of the normalized exponential attenuation function. The analytical result of the convolution operation presented in Equation (3) is given by the final expression shown in equation:
A sample of the nonlinear function
fitted to experimental data is shown in
Figure 3 below. Data corresponds to the highest concentrations of the trace elements (solution 5 in
Table 3) placed in the 0.6 mm wall cup with insert phantom configuration.
At the optimal position, three 3 min X-ray spectra were acquired. An X-ray spectra analysis methodology described in the next
Section 2.4 was employed to compute the K-shell XRF peak areas of Fe, Cu, Zn, and Se. These results were subsequently used to determine the calibration lines and detection limits.
2.4. Data Analysis
Following implementation of the OGIP method and the acquisition of the three 180 s X-ray spectra (number of counts versus photon energy), K-shell XRF peak areas of the four elements and their uncertainties were determined using the nonlinear fitting tools of the OriginPro 2020 software package (OriginLab, Northampton, MA, USA). Five different peak fitting functions
were written in the user-defined section of the Origin’s nonlinear fitting tool corresponding to five separate photon energy intervals that encompassed 12 observed XRF peaks. The general expression of the fitting function
was the sum of
Gaussian functions
, and a polynomial background function
as provided in the Equation (7) below. Equation (8) gives the expression of the Gaussian function
.
In Equation (8), , , and represent the center, standard deviation parameter, and area, respectively, of the Gaussian peak.
Initial values for the Gaussian peak center () and width () parameters were assigned based on the known XRF energy and the detector resolution as a function of photon energy. For the large amplitude peaks (e.g., Cu Kα), these parameters were allowed to vary during the chi-square minimization routine within limits predetermined in the nonlinear fitting routine of the OriginPro software. These parameter values were fixed in two separate cases: (i) X-ray spectra corresponding to the solution with zero elemental concentrations (i.e., blank sample) and (ii) fitting of lower amplitude peaks: Ni Kα, Fe Kβ, Ni Kβ, W Lβ17, Zn Kβ, Se Kα, and Se Kβ. In Equation (7), variables and are in counts, and is in keV units. Therefore, the peak area parameter in Equation (8) has counts keV units. All peak areas were converted to counts by dividing peak area parameter and its uncertainty by the measured energy calibration constant of 0.0259 keV photon energy per channel.
Reduced chi-square () value, its statistical significance, and fitted function plots were used to verify the quality of each fitting procedure. Chi-squared test was performed to determine if values were significantly larger than unity using the CHISQ.DIST.RT function of the Microsoft Office Excel software package (Microsoft, Redwood, WA, USA) which computed the p-value (right-tail probability of the chi-square distribution). Test results yielding a p-value below 5% indicate a value significantly larger than unity and a potential disagreement between the proposed model and data.
Table 6 provides details on all fitting functions and encompassed XRF peaks in the order of increasing photon energy.
A sample of the five peak-fitting functions is shown in the right-hand side plot of
Figure 4. The X-ray spectrum was one of the three 300 s trials acquired at the optimal position corresponding to solution 5 and 0.6 mm POM cup with insert phantom configuration.
Calibration lines were obtained by linear fitting of the measured K
α or K
β peak area values versus corresponding elemental concentrations of the solutions provided in
Table 3. For each solution and phantom configuration, the peak area and uncertainty values were computed as the weighted average and error of the fitting peak area parameters obtained from the three trials. Linear fitting was performed using a custom-made linear fitting tool in Excel. Analytical solutions for the chi-square minimization were used [
70]. The tool provided slope (denoted by
) and
y-axis intercept (denoted by
) parameter values, their uncertainties,
value, and its corresponding
p-value in the three possible cases (slope and intercept, zero intercept, and zero slope) for both weighted (weights computed as inverse squared uncertainty) and unweighted linear fitting.
Using the fitted
slope value, its uncertainty
, and the peak area uncertainty for zero elemental concentration
, the elemental detection limit denoted by
and its uncertainty
were computed using the following two equations:
Detection limit (DL) unit is mg/L as in
Table 3. Given the three-sigma Gaussian central confidence interval probability of ~99.7% [
70], Equation (9) definition implies that, on average, out of 1000 of peak area trials using a sample with elemental concentration equal to DL, only 3 trials will yield peak area measurements consistent with a zero concentration. Equation (10) gives the uncertainty on the DL estimate (
) based on the slope uncertainty (
). Further, detection limits from measured K
α and K
β peak area analysis:
and
can be combined to yield a single value using the weighted average formulae:
2.5. Radiation Dose Calculations
The accurate dose values of the experiments previously described can be obtained from dedicated experimental or Monte Carlo computational studies that are beyond the scope of this paper. However, an upper bound dose rate delivered to the aqueous solutions and POM plastic can be computed by simply assuming that all incident interacting photons are absorbed. Incident X-ray photon directions were parallel and encompassed in a cylinder with its axis as the microbeam’s direction and diameter equal to beam FWHM:
mm, as indicated in
Section 2.1. The precise distance between the microbeam direction and the central axis of the three phantom configurations was not measured in this study. To simplify analysis, one can assume that the beam crosses the middle of the cylindrical cup or the microbeam axis and cylinder central axis intersect. The aqueous solution mass (
) and POM plastic mass (
) can be computed as follows:
In Equations (13) and (14),
and
represent the inner diameter and wall thickness of the two POM cups, respectively. Their values are given in
Table 4 of
Section 2.2. For the cylindrical insert phantom configuration,
and
. The rate of the dose to POM plastic and water denoted by
solutions is then given by
In Equation (15),
denoted the microbeam’s photon count rate with the X-ray tube current, voltage, and filtration specified in
Section 2.2. The weighted average photon energy of the microbeam was:
. The weights (
) and photon energy values (
) (2 keV increments from 10 keV to 50 keV) were derived in a separate study and published [
76]. For each photon energy
, the fraction of interacting photons was computed using the mass attenuation coefficients of water,
, and POM,
, from the XCOM database [
73] and the following equation:
All calculations implied by Equations (13)–(16) were performed in an Excel spreadsheet.
5. Conclusions
Three phantom configurations mimicked a superficial blood vessel or cutaneous microvasculature. They consisted of two cylindrical POM plastic cups with 0.6 mm and 1.0 mm thick walls and a 5.3 mm POM cylinder inserted in the 0.6 mm wall cup filled with six aqueous solutions of varying Fe, Cu, Zn, and Se concentrations. It was assumed that the four elements were found only in blood. A microbeam XRF method was applied to measure detection limits for these elements. The dose to skin was estimated to be below 48 mGy for a 3 min exposure.
Detection limit ranges, in mg/L units, were: (36–100), (14–40), (3.7–10), and (2.1–3.4) for Fe, Cu, Zn, and Se, respectively. Fe was the only element with detection limits significantly lower than the median Fe human blood concentration of ~480 mg/L indicating the potential for further research toward medical applications. In vivo measurements of Fe concentration in human blood can improve current clinical diagnosis methods of Fe deficiency or excess but will require additional work to establish an accurate calibration method.
Cu, Zn, and Se detection limits were higher than their reported average human blood concentrations. In vivo measurements of their concentrations in cutaneous blood will be inherently linked to their skin concentrations. Instrumental modifications mitigating external XRF signal contamination and X-ray scatter, as well as finding a suitable calibration method are needed for measuring the concentrations of these elements in the skin and cutaneous blood.